Expression of peroxisome proliferator-activated receptor (PPAR)-γ in human lung cancer

Anticancer Research

Volumn 21, Issue 4 A, 2001, Pages 2471-2476

  Inoue, K I ^a   Kawahito, Y ^a   Tsubouchi, Y ^a   Yamada, R ^a   Kohno, M ^a   Hosokawa, Y ^a   Katoh, D ^a   Bishop Bailey, D ^a   Hla, T ^a   Sano, H ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Lung cancer; mRNA; Peroxisome proliferator activated receptor ; Protein

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; LUNG CANCER; LUNG PARENCHYMA; MALE; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL CELL CARCINOMA;

AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 0035156236     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Cancer statistics, 1999
2. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results
3. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
4. Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPARα, β and γ in the adult rat
5. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor
6. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
7. Activation of proliferator-activated receptor α and γ induces apoptosis of human monocyte-derived macrophages
8. Endothelial cell apoptosis induced by the peroxisome proliferator-activated receptor (PPAR) ligand 15-deoxy-delta 12, 14-prostaglandin J2
9. Ligand for peroxisome proliferator-activated receptorγ (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo
10. Terminal differentiation of human breast cancer through PPARγ
11. Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor-γ in non-small lung cancer
12. Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor (PPAR)-γ agonists through induction of apoptosis
13. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-α in humans
14. Auranofin inhibits interleukin-1β-induced transcript of cyclooxygenase-2 on cultured human synoviocytes
15. In vivo cyclooxygenase expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis
16. Peroxisome proliferator-activated receptor γ 1 expression is induced during cyclic adenosine monophosphate-stimulated differentiation of alveolar type II pneumocytes
17. Peroxisome proliferators alter lipid acquisition and elastin gene expression in neonatal rat lung fibroblasts
18. Novel retinoid-related molecules as apoptosis inducers and effective inhibitors of human lung cancer cells in vivo
19. Activation of PPAR gamma inhibits cell growth and induces apoptosis in human gastric cancer cells
20. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium
21. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo
22. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance
23. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
24. The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels in inversely correlated with non-small cell lung cancer progression
25. Is angiogenesis inhibition the Holy Grail of cancer therapy?